Home › Medical weight loss › Mounjaro
Once-weekly tirzepatide
Mounjaro Weight Loss Programme in Dubai
A once-weekly prescription programme led by licensed doctors and supported by specialist bariatric nurses and registered dietitians. Treatment begins with a medical assessment, not an online product sale.
Treatment overview
One weekly injection. Two appetite pathways.
Mounjaro contains tirzepatide, a prescription medicine that acts on both GIP and GLP-1 receptors. It is used with nutrition, activity and ongoing clinical support when a licensed doctor considers it suitable.
Many patients feel fuller sooner, stay satisfied for longer and find hunger, cravings and portions easier to manage. It is not insulin and is introduced gradually.
Your treatment is personalised. The highest dose is not automatically the best dose. Your doctor increases treatment only after clinical review.
GLP-1 pathway
Appetite support
Acts like a natural gut hormone that helps reduce hunger signals and brings earlier fullness, so portions feel easier to manage.
GIP pathway
Metabolic support
Supports the body’s glucose-dependent insulin response and blood-sugar regulation, and adds to the combined effect of the medicine.
Together
A combined effect
Tirzepatide also slows stomach emptying, particularly early in treatment. It is not insulin, and it works best alongside nutrition, movement and clinical follow-up.
Results in published studies
How much weight could I lose?
SURMOUNT-1 · 72 weeks
22.5%
Average reduction in starting body weight in the 15 mg efficacy analysis at 72 weeks.
In SURMOUNT-1, adults with obesity, or overweight with a weight-related condition, without type 2 diabetes received tirzepatide alongside lifestyle support. The 15 mg group achieved 22.5% average weight loss in the efficacy analysis, which assessed the effect before treatment discontinuation. In the analysis including participants regardless of discontinuation, the average was 20.9%.
In that broader analysis, average losses were 15.0% at 5 mg and 19.5% at 10 mg. These are study averages, not a target or promise for an individual. Your response depends on dose, duration, tolerability, starting weight and the habits you build.
Percentages refer to starting body weight. Study averages are not individual predictions. Separate trials differ in participants, duration and analysis, so these figures should not be read as a direct head-to-head comparison.
What these numbers mean
SURMOUNT-1 included 2,539 adults with obesity, or overweight plus at least one weight-related health condition, and excluded people with type 2 diabetes. Individual results vary, and not every patient needs or tolerates 15 mg.
Comparing medications
Mounjaro, Wegovy injection or Wegovy Oral?
All three are prescription GLP-1-based medicines, but they are different products with different doses. This is how they differ in practice.
Weekly injection
Mounjaro
- Tirzepatide, acting on GIP and GLP-1 receptors
- Once-weekly injection
- Starts at 2.5 mg, with maintenance doses up to 15 mg
- Dose steps no sooner than every four weeks
Weekly injection
Wegovy Injection
- Semaglutide, acting on GLP-1 receptors
- Once-weekly injection
- Starts at 0.25 mg and builds over 16 weeks towards 2.4 mg
- 2.4 mg is the highest dose available in our UAE programme
Daily tablet
Wegovy Oral
- Semaglutide tablet with SNAC absorption technology
- Once daily, taken on waking with plain water
- Starts at 1.5 mg, rising every 30 days as tolerated
- Oral and injectable doses cannot be compared directly
Choosing is not a matter of picking the biggest percentage. Published studies report different average results, but separate trials differ in participants, duration and analysis. Your doctor weighs your medical history, other medicines, side effects, previous treatment and the routine you are most likely to keep.
Clinical suitability
Is Mounjaro right for me?
Weight-management medication is commonly considered for adults with a BMI of 30 or above, or 27 or above with a weight-related condition. A BMI threshold alone does not guarantee suitability: your doctor reviews your history, current medicines and previous treatment before prescribing.
Your weekly routine
Simple, and supported
- One injection on the same chosen day, any time of day, with or without food
- Under the skin of the abdomen or thigh, rotating the site each week
- Training on your supplied pen, and a plan for a missed dose
- Nurse support when symptoms or questions arise
Alongside treatment
Medication works best with habits you can keep
Allure specialises exclusively in medical weight management. We coordinate assessment, treatment planning, progress reviews, nutritional guidance and aftercare within one 360° pathway. Prescribing and dose decisions are made by licensed UAE clinicians; your chosen programme determines the level of nurse and dietitian support.
Mounjaro is one part of a wider plan. Dietitian sessions are included in Premium programmes and available separately as an optional 60-minute consultation. If your needs change, we can review medication maintenance, gastric balloons or bariatric surgery where clinically appropriate.
Nutrition and protein
Registered dietitians help you eat in a way that suits your changing appetite, keeps protein up and fits your routine.
Hydration and symptoms
Drinking enough and adjusting meal size can ease nausea and reflux, especially at the start and after a dose increase.
Movement and sleep
Regular activity and good sleep support your results and how you feel. Small, steady changes are easier to sustain than big ones.
Reviews and plateaus
Monthly reviews cover appetite, meals and side effects, not only the scale. If progress stalls, your team adjusts the plan with you.
Gradual dose optimisation
Start low. Build gradually. Review regularly.
Treatment normally begins at 2.5 mg once weekly. Your doctor may increase the dose in 2.5 mg steps after at least four weeks, as tolerated. You may stay at a dose for longer if you need more time to adjust. Never change your dose without clinical direction.
2.5mgStarting doseWeeks 1–4
5mgMaintenance optionFrom week 5
7.5mgNext stepAfter 4+ weeks
10mgMaintenance optionAfter 4+ weeks
12.5mgNext stepAfter 4+ weeks
15mgMaximumAdult maximum
Missed a dose? Take it as soon as possible within four days (96 hours). If more than four days have passed, skip it and take the next dose on your usual day. Leave at least three days (72 hours) between doses.
Your Mounjaro journey
From first message to maintenance
1
Doctor consultation
An obesity doctor reviews your history, medicines and goals, and decides whether Mounjaro is suitable for you.
2
Treatment begins
Your medication is delivered and you are shown how to use the pen. Each dose is prescribed under clinician approval.
3
Monthly reviews
Your nurse and doctor review symptoms and progress, and adjust the dose only when the expected benefit outweighs side effects.
4
Maintenance
As you approach your goal, we plan how to protect your progress, whether that means continuing, adjusting or moving to another pathway. Before stopping or changing medication, discuss a maintenance plan with your clinician. Follow-up helps identify weight regain early and review the next step.
Programme options
Choose the support that fits you
Every programme includes an initial obesity doctor consultation, prescribed medication and medication delivery. Your Allure coordinator explains the options and current costs.
Monthly flexibility
Core
- Initial obesity doctor consultation
- Clinical suitability assessment
- Prescribed Mounjaro medication and delivery
- Monthly flexibility
Routine nurse support and scheduled dietitian consultations are not included.
Monthly programme
Support
- Initial medical assessment
- Prescribed medication and delivery
- Monthly treatment monitoring
- Clinically directed dose optimisation
- Symptom-management support
- Unlimited WhatsApp clinical support
Monthly programme
Premium
- Initial medical assessment
- Prescribed medication and delivery
- Monthly treatment monitoring
- Clinically directed dose optimisation
- Symptom-management support
- Unlimited WhatsApp clinical support
- Monthly dietitian consultation
- Ongoing bariatric nurse support
A structured start
3-Month Premium Programme
Medical, nursing, dietetic and behavioural support from day one.
- Initial obesity doctor consultation
- Three months of prescribed medication and delivery
- Three dietitian consultations
- Ongoing nurse support and behaviour coaching
- Clinically directed dose optimisation
- Unlimited WhatsApp clinical support
- Blood tests and clinical review at month three
- Smart scales at the start of your programme
- 12 months of Nutracheck Premium
After your three-month programme
Suitable patients may move to a three-month continuation programme with medication delivery, ongoing monitoring, basic clinical guidance, dose optimisation and WhatsApp clinical support.
Dietitian input is available if clinically required. Routine scheduled dietitian sessions, nurse reviews, blood tests, new scales and Nutracheck are not included in continuation.
Safety and suitability
Safe treatment begins with an honest medical review
Common side effects
- Nausea or vomiting
- Diarrhoea or constipation
- Reduced appetite
- Indigestion or reflux
- Abdominal discomfort or pain
Symptoms are often most noticeable when treatment starts or the dose increases. Contact the clinical team if they are severe, persistent or affecting hydration.
Tell your clinician before treatment if you
- Are pregnant, planning pregnancy or breastfeeding
- Have pancreatic, gallbladder or kidney problems
- Have severe gastroparesis or significant digestive disease
- Have diabetes, or use insulin or a sulfonylurea
- Have surgery, anaesthesia or deep sedation coming up
- Have a personal or family history of medullary thyroid carcinoma or MEN 2
Seek urgent medical help for
- Severe, persistent abdominal pain, especially if it travels to the back
- Severe allergic reaction: facial or throat swelling, breathing difficulty, fainting or widespread rash
- Repeated vomiting or signs of significant dehydration
- Upper abdominal pain with fever, jaundice or pale stools
UAE ambulance: 998. Tell the Allure clinical team as soon as it is safe to do so.
Do not combine Mounjaro with another tirzepatide or GLP-1 medicine unless specifically directed. Mounjaro can reduce the effectiveness of oral contraception: ask your doctor about additional or non-oral contraception for four weeks after starting and after each dose increase. This page does not replace the patient information leaflet.
Cost
How much does Mounjaro cost in Dubai?
Your cost depends on the prescribed dose, the length of your programme and the level of nurse and dietitian support you choose. Medication, delivery and your initial doctor consultation are included in every new programme.
What shapes the cost
- Dose: medication is prescribed and priced by dose, and your doctor sets the pace
- Support level: Core, Support, Premium or the structured 3-month start
- Programme length: monthly, or a three-month structured programme
- Extras: an optional 60-minute dietitian consultation is available separately
Medication supply is subject to availability and clinical suitability.
Questions worth asking any provider
- What is included beyond the medication itself?
- Do later dose changes affect the price?
- How are repeat prescriptions arranged?
- Who do I contact if side effects occur?
Your questions, answered
Mounjaro FAQs
Through an Allure programme, after a consultation with a licensed doctor. Prescribed medication and delivery are part of every new programme.
Yes. Mounjaro is a prescription medicine. At Allure it starts only after a doctor consultation and suitability review.
In SURMOUNT-1, average weight loss at 72 weeks was 15.0%, 19.5% and 20.9% at the 5 mg, 10 mg and 15 mg doses. These are study averages, and individual results vary.
Treatment normally begins at 2.5 mg once weekly and increases in 2.5 mg steps after at least four weeks, as tolerated and clinically directed.
Mounjaro contains tirzepatide, which acts on GIP and GLP-1 receptors. Wegovy contains semaglutide, a GLP-1 medicine. Doses are not equivalent, and your doctor advises which suits you.
Switching may be possible, but the timing and the new starting dose must be planned by your prescriber. Never switch on your own.
Yes. Wegovy Oral is a once-daily prescription tablet. Oral and injectable medicines are different formulations, and suitability is individual.
Appetite and weight can change after stopping, so plan maintenance with your clinician before you stop. Allure follow-up helps spot regain early.
Appetite changes can appear early, but meaningful weight loss builds over months as your dose and habits progress. The starting dose introduces treatment rather than delivering its full effect, and results vary.
No. Doses only increase after at least four weeks, when your doctor judges the benefit outweighs side effects, and some people stay on a lower maintenance dose. The best dose is the one that is effective and tolerable for you.
A licensed doctor assesses your suitability and issues any prescription. Allure coordinates your programme, medication delivery and ongoing support.
Nausea, vomiting, diarrhoea, constipation, reduced appetite, indigestion and abdominal discomfort, often when treatment starts or the dose rises. Contact the clinical team early if symptoms are severe, persistent or affect hydration.
It can reduce the effectiveness of oral contraception after starting and after each dose increase. Ask your doctor about additional or non-oral contraception for four weeks after each change.
Take it as soon as possible within four days (96 hours). If more than four days have passed, skip it and take the next dose on your usual day, keeping at least three days between doses.
Yes. Medication works best with balanced nutrition, enough protein and fluids, movement and sleep, with dietitian and nurse support where your programme includes it.
Other options
Explore the other medication pathways
All medication programmes
Compare pathways, and see how medication, balloon and surgery connect.
Begin your Mounjaro assessment
Speak to an Allure patient coordinator about suitability, programme support and costs. Your next step is a medical assessment and a plan built around you.
Patient information only. This page is not a prescription, diagnosis or substitute for individual medical advice. All treatment is subject to consultation, clinical suitability, licensed prescribing, medicine availability and UAE health regulations. Results vary.
Evidence: Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216. Mounjaro is a registered trademark of Eli Lilly. Allure Weightloss is independent of Eli Lilly.